Rep. Robert Bresnahan, Jr. Sells UnitedHealth Group Incorporated (NYSE:UNH) Shares

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on May 31st, the Representative disclosed that they had sold between $15,001 and $50,000 in UnitedHealth Group stock on May 15th. The trade occurred in the Representative's "JP MORGAN BROKERAGE ACCOUNT" account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Zimmer Biomet NYSE: ZBH on 5/15/2025.
• Sold $15,001 - $50,000 in shares of Elevance Health NYSE: ELV on 5/15/2025.
• Sold $15,001 - $50,000 in shares of PepsiCo NASDAQ: PEP on 5/15/2025.
• Sold $1,001 - $15,000 in shares of WEC Energy Group NYSE: WEC on 5/15/2025.
• Purchased $15,001 - $50,000 in shares of Advanced Micro Devices NASDAQ: AMD on 5/15/2025.
• Purchased $1,001 - $15,000 in shares of Hershey NYSE: HSY on 5/15/2025.
• Purchased $1,001 - $15,000 in shares of Kraft Heinz NASDAQ: KHC on 5/15/2025.
• Sold $1,001 - $15,000 in shares of Exxon Mobil NYSE: XOM on 5/15/2025.
• Sold $1,001 - $15,000 in shares of Danaher NYSE: DHR on 5/15/2025.
• Sold $1,001 - $15,000 in shares of International Flavors & Fragrances NYSE: IFF on 5/15/2025.

UnitedHealth Group Stock Up 2.5%

UnitedHealth Group stock traded up $7.40 during mid-day trading on Friday, reaching $303.24. 12,558,756 shares of the company's stock were exchanged, compared to its average volume of 6,994,891. The company has a market cap of $275.08 billion, a P/E ratio of 19.56, a P/E/G ratio of 1.37 and a beta of 0.44. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a fifty day moving average of $413.43 and a 200-day moving average of $486.09.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter last year, the company earned $6.91 earnings per share. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.92%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director John H. Noseworthy bought 300 shares of the business's stock in a transaction on Wednesday, May 14th. The shares were acquired at an average price of $312.16 per share, with a total value of $93,648.00. Following the transaction, the director now owns 6,063 shares of the company's stock, valued at $1,892,626.08. The trade was a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock worth $31,607,768 over the last 90 days. Company insiders own 0.33% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on UNH shares. Oppenheimer reduced their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Morgan Stanley reduced their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Wall Street Zen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. KeyCorp reduced their price objective on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a report on Monday. Finally, Hsbc Global Res lowered shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $428.43.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of UNH. Capital & Planning LLC boosted its holdings in shares of UnitedHealth Group by 19.2% in the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock valued at $248,000 after acquiring an additional 79 shares in the last quarter. Brighton Jones LLC boosted its holdings in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after acquiring an additional 28,231 shares in the last quarter. Union Bancaire Privee UBP SA purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $27,233,000. Revolve Wealth Partners LLC lifted its stake in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after purchasing an additional 2,324 shares during the period. Finally, Cyr Financial Inc. lifted its stake in shares of UnitedHealth Group by 11.1% in the fourth quarter. Cyr Financial Inc. now owns 1,515 shares of the healthcare conglomerate's stock valued at $766,000 after purchasing an additional 151 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election. Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.